Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Jianhua Shi et al.|The Lancet Respiratory Medicine|2020Cited by 504
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-AnalysisShixue Chen, Yi Hu, Zhibo Zhang et al.|Frontiers in Oncology|2021Cited by 125
Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phaseQi Xiong, Yi Hu, Ziwei Huang et al.|Cancer Immunology Immunotherapy|2020Cited by 73
Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stabilityZhiqiang Ma, Yi Hu|Military Medical Research|2022Cited by 30
Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer CellsYi Hu, Michael G. Brattain|Journal of Biological Chemistry|2005Cited by 25